ENTRY       D01699                      Drug
NAME        Darifenacin hydrobromide (JAN/USAN);
            Enablex (TN)
PRODUCT
  GENERIC   DARIFENACIN (Alembic Pharmaceuticals Limited)
            DARIFENACIN (Alembic Pharmaceuticals)
            DARIFENACIN (Aurobindo Pharma Limited)
            DARIFENACIN (Cipla USA)
            DARIFENACIN (Macleods Pharmaceuticals Limited)
            DARIFENACIN (POLYGEN PHARMACEUTICALS)
            DARIFENACIN (Rising Pharma Holdings)
            DARIFENACIN (Torrent Pharmaceuticals Limited)
            DARIFENACIN HYDROBROMIDE (Proficient Rx LP)
            DARIFENACIN HYDROBROMIDE (Xiromed)
FORMULA     C28H30N2O2. HBr
EXACT_MASS  506.1569
MOL_WEIGHT  507.4619
CLASS       Neuropsychiatric agent
             DG01491  Muscarinic cholinergic receptor antagonist
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: G04BD10
            Chemical structure group: DG00482
            Product (DG00482): D01699<US>
EFFICACY    Overactive bladder agent, Muscarinic acetylcholine receptor antagonist
TARGET      CHRM3 [HSA:1131] [KO:K04131]
  PATHWAY   hsa04080(1131)  Neuroactive ligand-receptor interaction
            hsa04725(1131)  Cholinergic synapse
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04B UROLOGICALS
                G04BD Drugs for urinary frequency and incontinence
                 G04BD10 Darifenacin
                  D01699  Darifenacin hydrobromide (JAN/USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Genitourinary Agents
              Antispasmodics, Urinary
               Cholinergic Muscarinic Antagonists
                Darifenacin
                 D01699  Darifenacin hydrobromide (JAN/USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00482  Darifenacin
                D01699  Darifenacin hydrobromide
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00482  Darifenacin
                D01699  Darifenacin hydrobromide
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00482  Darifenacin
                 D01699  Darifenacin hydrobromide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                CHRM3
                 D01699  Darifenacin hydrobromide (JAN/USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01699
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01699
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01699
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01699
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D01699
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00482  Darifenacin
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00482  Darifenacin
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00482  Darifenacin
DBLINKS     CAS: 133099-07-7
            PubChem: 7848762
            ChEBI: 31455
            LigandBox: D01699
ATOM        33
            1   X   Br   23.8000  -21.2800
            2   C1x C    14.9100  -22.2600
            3   C1x C    16.3100  -22.2600
            4   C1y C    16.7426  -20.9285
            5   C1x C    15.6100  -20.1056
            6   N1y N    14.4774  -20.9285
            7   C1b C    13.2776  -20.2300
            8   C1b C    12.0651  -20.9300
            9   C8y C    10.8527  -20.2300
            10  C8x C     9.6403  -20.9300
            11  C8y C     8.4278  -20.2300
            12  C1d C    17.9424  -20.2300
            13  C8y C    19.1549  -20.9300
            14  C8y C    17.9399  -18.8301
            15  C8x C    19.1361  -18.1365
            16  C8x C    19.1335  -16.7365
            17  C8x C    17.9197  -16.0388
            18  C8x C    16.7235  -16.7324
            19  C8x C    16.7261  -18.1324
            20  C8x C    19.1549  -22.3300
            21  C8x C    20.3673  -23.0300
            22  C8x C    21.5797  -22.3300
            23  C8x C    21.5797  -20.9300
            24  C8x C    20.3673  -20.2300
            25  C8x C    10.8527  -18.8300
            26  C8x C     9.6403  -18.1300
            27  C8y C     8.4278  -18.8300
            28  O2x O     7.0963  -18.3974
            29  C1x C     6.2734  -19.5300
            30  C1x C     7.0963  -20.6626
            31  C5a C    20.9749  -18.6200
            32  O5a O    22.1796  -19.3741
            33  N1a N    21.0247  -17.2202
BOND        36
            1     2   3 1
            2     3   4 1
            3     4   5 1
            4     5   6 1
            5     2   6 1
            6     6   7 1
            7     7   8 1
            8     8   9 1
            9     9  10 2
            10   10  11 1
            11    4  12 1 #Down
            12   12  13 1
            13   12  14 1
            14   14  15 1
            15   15  16 2
            16   16  17 1
            17   17  18 2
            18   18  19 1
            19   14  19 2
            20   13  20 2
            21   20  21 1
            22   21  22 2
            23   22  23 1
            24   23  24 2
            25   13  24 1
            26    9  25 1
            27   25  26 2
            28   26  27 1
            29   27  11 2
            30   27  28 1
            31   28  29 1
            32   29  30 1
            33   11  30 1
            34   12  31 1
            35   31  32 2
            36   31  33 1
///
